Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis-Reference-Cited by-同舟云学术

Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis

Published:2021-07 Issue: Volume:151 Page:3-13
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Riedl Jakob M.,Posch Florian,Horvath Lena^ORCID,Gantschnigg Antonia^ORCID,Renneberg Felix,Schwarzenbacher Esther,Moik Florian^ORCID,Barth Dominik A.^ORCID,Rossmann Christopher H.,Stotz Michael,Schaberl-Moser Renate,Pichler Martin,Stöger Herbert,Greil Richard,Djanani Angela,Schlick Konstantin,Gerger Armin^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference31 articles.

1. European cancer mortality predictions for the year 2020 with a focus on prostate cancer;Carioli;Ann Oncol,2020

2. Cancer statistics, 2020;Siegel;CA A Cancer J Clin,2020

3. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer;Conroy;N Engl J Med,2018

4. Epidemiology of pancreatic cancer;Ilic;World J Gastroenterol,2016

5. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J Clin Oncol,1997

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibitory effects of the combination of rapamycin with gemcitabine plus paclitaxel on the growth of pancreatic cancer tumors;2024-08-22

2. Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer;Frontiers in Oncology;2024-07-17

3. Pancreatic cancer cells exchange ribosomes through tunneling nanotubes;2024-06-08

4. Guiding post-pancreaticoduodenectomy interventions for pancreatic cancer patients utilizing decision tree models;Frontiers in Oncology;2024-05-30

5. The Trends and Outcomes of Initial Palliative Chemotherapy in Patients with Pancreatic Cancer in Korea Based on National Health Insurance Service Data;Journal of Clinical Medicine;2024-05-30